Stock data
Precision BioSciences, Inc. (DTIL)
Precision BioSciences, Inc. (DTIL) reported revenue of US$34.26M and net income of -US$45.72M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$34.26M | — | -US$52.15M | -US$45.72M | — |
| 2024 | US$68.70M | — | -US$26.16M | US$7.17M | — |
| 2023 | US$48.73M | — | -US$43.74M | -US$61.32M | — |
| 2022 | US$25.10M | — | -US$62.31M | -US$111.64M | — |
| 2021 | US$115.53M | — | -US$39.38M | -US$30.60M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.00M | -US$32.65M | — |
| 2026-03-31 | US$10.84M | -US$18.44M | — |
| 2025-12-31 | US$34.20M | US$20.13M | — |
| 2025-09-30 | US$0.01M | -US$21.77M | — |
| 2025-06-30 | US$0.02M | -US$23.52M | — |
| 2025-03-31 | US$0.03M | -US$20.57M | — |
| 2024-12-31 | US$0.64M | -US$17.75M | — |
| 2024-09-30 | US$0.58M | -US$16.43M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.